Influence of grapefruit juice intake on aflatoxin B 1 (AFB 1 )-induced liver DNA damage was examined using a Comet assay in F344 rats given 5 mg/kg AFB 1 by gavage. Rats allowed free access to grapefruit juice for 5 days prior to AFB 1 administration resulted in clearly reduced DNA damage in liver, to 65% of the level in rats that did not receive grapefruit juice. Furthermore, rats treated with grapefruit juice extract (100 mg/kg per os) for 5 days prior to AFB 1 treatment also reduced the DNA damage to 74% of the level in rats that did not receive grapefruit juice. No significant differences in the portal blood and liver concentrations of AFB 1 were observed between grapefruit juice intake rats and the controls. In an Ames assay with AFB 1 using Salmonella typhimurium TA98, lower numbers of revertant colonies were detected with hepatic microsomes prepared from rats administered grapefruit juice, compared with those from control rats. Microsomal testosterone 6b-hydroxylation was also lower with rats given grapefruit juice than with control rats. Immunoblot analyses showed a significant decrease in hepatic CYP3A content, but not CYP1A and CYP2C content, in microsomes of grapefruit juice-treated rats than in non-treated rats. No significant difference in hepatic glutathione S-transferase (GST) activity and glutathione content was observed in the two groups. GSTA5 protein was not detected in hepatic cytosol of the two groups. In microsomal systems, grapefruit juice extract inhibited AFB 1 -induced mutagenesis in the presence of a microsomal activation system from livers of humans as well as rats. These results suggest that grapefruit juice intake suppresses AFB 1 -induced liver DNA damage through inactivation of the metabolic activation potency for AFB 1 in rat liver.
Introduction
Aflatoxin B 1 (AFB 1 ) is one of the most common mycotoxins found in human foodstuffs such as corn, peanuts and cotton seeds. This mycotoxin is a potent hepatocarcinogen in experimental animals and also probably in humans (1±3). Because of detection in a variety of human foodstuffs, AFB 1 is believed to be a carcinogen of human health risk. This chemical is biotransformed by cytochrome P450 (CYP) to the reactive intermediate aflatoxin B 1 8,9-epoxide (AFBO) to exert its carcinogenic effect (4±6). AFBO is capable of reacting with DNA, resulting in the production of DNA damage. There is considerable evidence suggesting that CYP3A2 and CYP2C11, but not CYP1A2, are involved in the production of AFBO in rats (7±9). CYP1A, CYP2B and CYP3A also metabolize AFB 1 to other metabolites, aflatoxin M 1 , aflatoxin P 1 and aflatoxin Q 1 . The production of these metabolites is considered to represent detoxification reactions (10, 11) . Thus, CYP3A forms are involved in detoxification and activation of AFB 1 . Another major detoxification pathway is glutathione conjugation of AFBO by glutathione S-transferase (GST) (12) . The rat GSTA5 subunit (also called Yc2) plays a major role in protection against AFB 1 -induced DNA damage (13, 14) . Pretreatment of rats with GST inducers such as ethoxyquin, oltipraz and butylated hydroxytoluene resulted in protection against AFB 1 -induced DNA damage and carcinogenesis (15) . Thus, AFBO production and its glutathione conjugating activity are considered to be major determinants of susceptibility to AFB 1 -induced hepatocarcinogenesis.
Numerous epidemiological studies suggest a role of dietary habit in human cancer incidence. Foods sometimes contain carcinogens as well as anticarcinogenic compounds. It has been shown that various fruits, vegetables and teas reduce chemical tumorigenesis in experimental animals. Anticarcinogenic activity of components in these foods has been widely investigated (16) . Grapefruit juice is known to alter the pharmacokinetics and efficacies of various drugs catalyzed by CYP3A, including dihydropyridine calcium channel blockers and cyclosporin A (17±19). Co-administration of grapefruit juice with these drugs results in a substantial increase in their oral bioavailability. Microsomal metabolism of these drugs was inhibited by components of grapefruit juice (20±22). The effects of grapefruit juice are mainly attributed to the inhibition of CYP3A activities in the gastrointestinal tract rather than in the liver in human (23, 24) . Inhibition of P-glycoprotein activity, which controls excretion of these drugs into the intestinal lumen, is also at least in part involved in the increase in bioavailability with grapefruit juice (25) . Thus, we examined whether grapefruit juice intake enhances AFB 1 -induced liver DNA damage concomitant with an increase in hepatic and portal blood concentrations of AFB 1 in rats.
Unexpectedly, we have shown that grapefruit juice intake suppresses AFB 1 -induced liver DNA damage in rats. Furthermore, the suppressive effect is likely to be attributable to a decrease in the capacity for metabolic activation of AFB 1 through hepatic CYP3A activity, rather than an effect on transport systems or metabolism in the gastrointestinal tract.
Materials and methods
Chemicals and animals AFB 1 was purchased from Wako Pure Chemicals (Osaka, Japan). Male Fischer 344 rats (8±10 weeks old) were obtained from Japan SLC Inc. (Hamamatsu, Japan). Grapefruit juice (Tropicana) distributed by Kirin Beverages Inc. (Tokyo, Japan) was used. Polyclonal antibodies against rat GSTA5 were kindly provided by Dr J.D.Hayes (Dundee University, Dundee, UK). Grapefruit juice extract was prepared by extraction of grapefruit juice with ethyl acetate as described previously (26) .
Comet assay
Rats were allowed free access to grapefruit juice for 5 days or were given grapefruit juice extract (100 mg/kg in saline) once a day for 5 days by gavage prior to oral administration of AFB 1 (5 mg/kg). Rats were given AFB 1 3 h following the final treatment with grapefruit juice extract. Rats were killed 3 h after AFB 1 treatment to remove the livers. Comet assays were conducted as described previously (27, 28) . Liver nuclei slides were prepared and placed in chilled lysing solution (2.5 M NaCl, 100 mM EDTA, 10 mM Trizma base, 1% sarkosyl, 10% DMSO and 1% Triton X-100, pH 10) and kept at 0 C for 460 min, then in chilled alkaline solution (300 mM NaOH and 1 mM EDTA, pH 13) at 0 C for 10 min. Electrophoresis was performed at 0 C for 15 min at 40 V and~50 mA. The slides were neutralized and stained with 50 ml of a 20 mg/ml ethidium bromide solution. Fifty nuclei were analyzed per mouse at 200Â magnification by fluorescence microscopy. The differences between the length of the whole comet and the diameter of the head were calculated.
Ames assay
The Ames assay was performed as described previously (29) . The mutation assay was performed using Salmonella typhimurium TA98. All assays were conducted using a preincubation method (37 C, 10 min). The incubation mixture (700 ml) contained 50 mg of liver microsomes, cofactors, including 2 mmol NADPH and 2 mmol NADH, AFB 1 (50 ml in phosphate-buffered saline) and bacteria (100 ml). All experiments were conducted using triplicate plates per sample.
Inhibition of metabolic activation with grapefruit juice extract Grapefruit juice extract was dissolved in methanol. The grapefruit juice extract was preincubated at 37 C for 10 min in a reaction mixture containing microsomes, cofactors and bacteria prior to addition of AFB 1 . The reaction was started by addition of AFB 1 . All reactions were carried out at 37 C for 10 min.
Liver and serum AFB 1 concentration Blood samples were taken from portal veins of rats treated with AFB 1 (5 mg/ kg) orally at indicated time points under ether anesthesia. Livers were isolated 45 min after AFB 1 administration. Serum (25 ml) was mixed with 25 ml of saline, 15 ml of 4-methylumbelliferone (2.5 mM) as an internal standard and 35 ml of ice-cold methanol and then cooled at À20 C for 3 h. The supernatants after centrifugation for 10 min at 15 000 g were subjected to HPLC (30, 31) . For hepatic samples, liver homogenate (100 ml) was mixed with 100 ml of saline, 20 ml of 4-methylumbelliferone (10 mM) as an internal standard and 400 ml of ethyl acetate. The mixtures were centrifuged for 10 min at 15 000 g after vortexing and the organic layer was isolated and dried under a current of N 2 gas. The residues were redissolved with 100 ml of saline and 100 ml of methanol. HPLC analyses were performed with a Jasco Intelligent Model PV-980 pump and FP-920S fluorescence detector. AFB 1 was separated with a Capcellpak (C18) (150 Â 4.6 mm) column (Shiseido) using a flow rate of 1 ml/min at 40 C. The column was eluted with a gradient of solvent A and solvent B: solvent A, water; solvent B, 1.1 mM HClO 4 /NaClO 4 (pH 3): methanol:tetrahydrofuran (57:38:5). The chromatography procedure used linear gradients as follows: 0 min, 95% A:5% B; 23 min, 40% A:60% B; 28 min, 15% A:85% B; 45 min, 15% A:85% B. AFB 1 was detected using the fluorescence setting at an excitation wavelength of 365 nm and emission wavelength of 440 nm.
Microsomal testosterone hydroxylation
The reaction mixture (500 ml) consisted of 100 mg microsomal protein, 100 nmol testosterone and a NADPH generating system in 100 mM potassium phosphate buffer (pH 7.5). The reaction was performed at 37 C for 10 min. HPLC analyses were performed with a Jasco Intelligent Model PV-980 pump and Jasco UV-970 detector. Testosterone metabolites were separated with a Chemcosorb 5-ODS-H (150 Â 6 mm) column using a flow rate of 1 ml/min. The column was eluted with water and methanol. The chromatography procedure used linear gradients as follows: 0 min, 60% water:40% methanol; 10 min, 52% water:48% methanol; 35 min, 40% water:60% methanol; 40 min, 30% water:70% methanol; 45 min, 30% water:70% methanol. Testosterone metabolites were detected at 240 nm.
GST activity GST activities were determined as described previously (32) . The reaction mixture for 1-chloro-2,4-dinitrobenzene (CDNB) GST activity (100 ml) contained 2 mg cytosolic protein, 1 mM reduced glutathione (GSH) and 1 mM CDNB in 100 mM potassium phosphate buffer (pH 6.5). The reaction mixture for 1,2-dichloro-4-nitrobenzene (DCNB) GST activity (100 ml) contained 2 mg cytosolic protein, 1 mM GSH and 1 mM DCNB in 100 mM potassium phosphate buffer (pH 7.5). The reaction was performed at 25 C for 2.5 min. GST activities were measured at 340 and 345 nm for CDNB and DCNB, respectively.
Liver GSH content
Liver was homogenized in a 4-fold volume of cold 1 M perchloric acid solution with 2 mM EDTA. After the denatured protein was removed by centrifugation, the supernatant was assayed for GSH according to the method of Griffith (33) . The reaction mixture (1 ml) contained 5 mM EDTA, 0.6 mM 5,5
H -dithiobis (2-nitrobenzoic acid), 0.2 mM NADPH, 0.2 ml supernatant and 0.5 U GSH reductase in 100 mM potassium phosphate buffer (pH 7.5). Incubation was initiated by the addition of GSH reductase and the rate of formation of 2-nitro-5-thiobenzoic acid was measured at 412 nm.
Immunoblot analysis
Microsomal proteins were separated by SDS±PAGE and transferred to a nitrocellulose sheet. The sheets were immunostained with polyclonal antibodies raised against human CYP3A4, rat CYP3A2 (34), rat CYP1A1, rat CYP2C11, rat microsomal epoxide hydrolase (mEH) or rat GSTA5. Horseradish peroxidase-conjugated goat anti-rabbit IgG and 3,3
H -diaminobenzidine, tetrahydrochloride were used for staining. The stained sheets were scanned with an Epson GT-8700 scanner and their intensities were measured by NIH image (version 1.59) software (Bethesda, MD).
Statistical analysis
Data were analyzed by Student's t-test. All statistical tests were performed using StatView-J 4.02 and a P value of 50.05 was considered significant.
Results
Influence of grapefruit juice on AFB 1 -induced liver DNA damage AFB 1 (5 mg/kg) was given orally to rats which were allowed free access to grapefruit juice for 5 days prior to exposure to the mycotoxin. AFB 1 -induced DNA damage was evaluated by the Comet assay. The migration of tailed nuclei was measured as an indicator of DNA damage. The migration of tailed nuclei increased 6.3 times in liver nuclei of AFB 1 -treated rats as compared with those of vehicle-treated rats ( Figure 1A) . In vehicle-treated groups, no significant difference was found in the migration of tailed nuclei between grapefruit juice pretreated and non-pretreated rats. On the other hand, the (A) Rats were allowed free access to grapefruit juice 5 days before AFB 1 (5 mg/kg) was orally administered. (B) Rats were given grapefruit juice extract (100 mg/kg in saline) once a day for 5 days by gavage prior to oral administration of AFB 1 (5 mg/kg). Liver nuclei were isolated 3 h after AFB 1 treatment. Migration was measured as the difference between the length of the whole comet and the diameter of the head. Values represent means AE SD (n 9).
Ã,ÃÃ Significant difference from corresponding control group ( Ã P 5 0.05, ÃÃ P 5 0.01). GFJ, grapefruit juice; GFJE, grapefruit juice extract.
AFB 1 -induced migration of tailed nuclei was unexpectedly reduced in grapefruit juice-pretreated rats to just 65% of the tail observed in liver nuclei from control rats that were not pretreated with grapefruit juice. To determine whether lipidsoluble components of grapefruit juice such as furanocoumarin derivatives suppress AFB 1 -induced liver DNA damage in rats, the influence of pretreatment with an ethyl acetate extract of grapefruit juice was examined. One milligram of grapefruit juice extract is derived from 1 ml of grapefruit juice. Grapefruit juice extract (100 mg/kg per os) was administered to rats once a day for 5 days before AFB 1 treatment. AFB 1 -induced migration of tailed nuclei was reduced in grapefruit juice extract-pretreated rats to 74% of the vehicle-pretreated rats ( Figure 1B ).
Absorption of AFB 1
Grapefruit juice intake is known to inhibit metabolism and transport of drugs in the intestinal tract. Therefore, the portal blood concentration of AFB 1 was measured to determine whether grapefruit juice intake affects absorption of AFB 1 from the intestine. However, no significant difference in AFB 1 concentration between rats with and without grapefruit juice intake was observed until 45 min after 5 mg/kg AFB 1 administration (Figure 2A ). Thus, hepatic AFB 1 content at 45 min after AFB 1 administration was measured to compare the level of influx and efflux of AFB 1 across the liver between rats of the two groups. No significant difference was observed in hepatic AFB 1 content between the two groups ( Figure 2B ).
Metabolic activation of AFB 1 in liver microsomes
The capacity for metabolic activation of AFB 1 in rat liver microsomes was evaluated by the Ames assay. At 0.5 mg/ plate AFB 1 , the number of revertant colonies increased, depending on the amount of microsomal protein (from 25 to 100 mg/plate) ( Figure 3 ). Numbers of revertant colonies were significantly decreased with liver microsomes prepared from grapefruit juice intake rats compared with those from control rats. In rats, two forms of cytochrome P450, CYP2C11 and CYP3A2, are known to metabolically activate AFB 1 . To evaluate the influence of grapefruit juice intake on CYP3A2 and CYP2C11 activities in liver microsomes, testosterone 6b-hydroxylase and 16a-hydroxylase activities were measured as indicators of CYP3A2 and CYP2C11, respectively.
Microsomal testosterone 6b-hydroxylation by liver microsomes in grapefruit juice intake rats was decreased to 50% of the control liver level (Figure 4 ). Grapefruit juice intake tended to decrease microsomal testosterone 16a-hydroxylase activity in rat livers, but there was no statistically significant difference in activity between the grapefruit juice intake rats and the control rats (n 5). Thus, to assess whether the decrease in metabolic activation potency is attributable to the change in content of CYP3A forms, immunoblot analyses of CYP3A forms were performed using antibodies raised against CYP3A4. As shown in Figure 5 , the hepatic CYP3A level in grapefruit juice intake rats was reduced to 50% of control livers. On the other hand, no significant differences in CYP1A, CYP2C and mEH levels were found between rats with and without grapefruit juice intake ( Figure 6A ).
Detoxification of AFB 1 reactive intermediates in liver GST and mEH mediate inactivation of the AFB 1 reactive intermediate AFBO prior to its reaction with DNA. Typical substrates for GST (CDNB and DCNB) were thus used to evaluate GST activity in liver cytosol (32) . These GST activities were not significantly different between control and grapefruit juice intake groups ( Figure 7A and B). Rats were allowed free access to grapefruit juice 5 days before AFB 1 (5 mg/kg) was administered by gavage. Blood was taken from the portal vein of the rats at the indicated time points. Liver was isolated from the rats 45 min after AFB 1 administration. AFB 1 concentration was measured by HPLC. Data are shown as means AE SD from five different animals. Fig. 3 . AFB 1 -induced mutagenesis in Salmonella typhimurium TA98 with liver microsomes from grapefruit juice-pretreated rats. Microsomal proteins were prepared from rats allowed free access to grapefruit juice for 5 days. Ames assays were performed with the indicated amount (25±100 mg) of rat liver microsomal protein and AFB 1 (0.5 mg/plate). Data are shown as means AE SD (n 5).
ÃÃÃ Significant difference from corresponding control group at P 5 0.001. Fig. 4 . Testosterone hydroxylase activity in liver microsomes from grapefruit juice pretreated rats. Microsomal proteins were prepared from rats allowed free access to grapefruit juice for 5 days. Experimental details of the measurement of testosterone hydroxylase activity are described in Materials and methods. Data are shown as means AE SD (n 5).
ÃÃÃ Significant difference from control group at P 5 0.001.
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Furthermore, no differences in GSH content ( Figure 7C ) in liver and mEH protein level ( Figure 6A ) in liver microsomes between the two groups were observed. GSTA5 was identified as the major AFBO-metabolizing enzyme (14) . Thus, the expression level of GSTA5 protein was measured by western blot analysis. GSTA5 protein was not detected in liver cytosol of either the control or grapefruit juice intake male rats ( Figure 6B ).
Inhibition of metabolic activation of AFB 1 with grapefruit juice extract Metabolic activation of AFB 1 was assessed with the Ames assay to evaluate whether grapefruit juice components inhibit the metabolic activation of AFB 1 . A clear increase in revertant colonies was detected in the presence of an activation system using rat microsomes (50 mg protein/reaction) ( Figure 8A) . A 450% decrease in AFB 1 -induced mutagenicity was observed in the presence of grapefruit juice extract (25 mg/reaction) in the preincubation mixture. On the other hand, no clear increase in revertant numbers was observed in the Ames test with 50 mg human liver microsomes (0.5 mg AFB 1 /plate) ( Figure 8B ). Addition of more than 20 times higher amounts of AFB 1 resulted in the production of revertants. Addition of grapefruit juice extract inhibited AFB 1 -induced mutagenesis in the presence of an activation system using human microsomes.
Discussion
The present study has employed the Comet assay to demonstrate that grapefruit juice intake protects rats against AFB 1 -induced liver DNA damage. This assay also revealed that pretreatment of rats with grapefruit juice extracts containing furanocoumarin derivatives protected against the genotoxic effects of the mycotoxin. These results suggest that lipid-soluble compounds in grapefruit juice that can be extracted with ethyl acetate are the major components protecting against DNA damage caused by AFB 1 . A significant Fig. 5 . Quantitation of CYP3A forms in liver microsomes. Microsomal proteins (5 mg) were subjected to SDS±PAGE on 8% gels and electrically transferred to nitrocellulose membranes for immunostaining with anti-CYP3A4 antibody. CYP3A1/2 levels were quantitated as described in Materials and methods. Data are shown as means AE SD (n 5). Ã Significant difference from control group at P 5 0.05. Fig. 6 . Immunoblot analyses of drug metabolizing enzymes. (A) Microsomal proteins (5 mg) were subjected to SDS±PAGE on 8% gels. The proteins were immunostained with anti-rat CYP3A2, anti-rat CYP1A1, anti-rat CYP2C11 and anti-rat mEH antibodies. Lanes 1±3, liver microsomes of rats without grapefruit juice intake; lanes 4±6, liver microsomes of grapefruit juice intake rats. (B) Cytosolic proteins (10 mg) were subjected to SDS± PAGE on 12% gels. The proteins were immunostained with anti-rat GSTA5 antibody. Lane 1, female rat liver microsomes; lanes 2±4, liver microsomes of male rats without grapefruit juice intake; lanes 5±7, liver microsomes of grapefruit juice intake male rats; lane 8, female mouse microsomes. Fig. 7 . GST activities and GSH content in rat liver. GST activity in rat liver cytosol was measured using (A) CDNB and (B) DCNB as substrates. (C) GSH content in rat livers. Liver cytosols were prepared from rats allowed free access to grapefruit juice for 5 days. Data are shown as means AE SD (n 5).
M. Miyata et al. decrease in the capacity for metabolic activation of AFB 1 was found in the Ames assay using liver microsomes from grapefruit juice-pretreated rats. Microsomal testosterone 6b-hydroxylation in liver from grapefruit juice-pretreated rats was also reduced to 50% of the level in control rats. The decrease in CYP3A content of liver microsomes from grapefruit juicepretreated rats was consistent with the decrease in microsomal testosterone 6b-hydroxylation. In contrast, liver testosterone 16a-hydroxylation, correlating with CYP2C11 content, was not significantly different between the two groups. However, grapefruit juice intake tended to decrease microsomal testosterone 16a-hydroxylation in rat livers. It remains to be determined whether CYP2C11 contributes to the suppression of AFB 1 -induced liver DNA damage in grapefruit juice intake rats. In a previous experiment we demonstrated that grapefruit juice intake suppressed 2-amino-1-methyl-6-phenylimidazo [4,5-b] pyridine (PhIP)-induced colon DNA damage in rats (29) . However, no significant decrease in the capacity for metabolic activation of PhIP was observed in liver S9 fraction from grapefruit juice intake rats. Furthermore, no significant difference in CYP1A level was found between rats with and without grapefruit juice intake in the present study. Grapefruit juice intake is unlikely to affect hepatic CYP1A activity in rats. These results indicate that the decrease in hepatic CYP3A level caused by grapefruit juice intake is primarily involved in suppression of the capacity for metabolic activation of AFB 1 in rat livers. Furthermore, grapefruit juice extract inhibited AFB 1 -induced mutagenesis in the preincubation system using rat liver microsomal proteins ( Figure 8A ). This result supports the idea that grapefruit juice components exert a suppressive effect through dual mechanisms, direct inhibition of hepatic CYP3A activity and a decrease in CYP3A content.
It has been reported that pretreatment of rats with butylated hydroxyanisole, ethoxyquin or oltipraz elevates expression of the GSTA5 subunit. The change results in protection against AFB 1 -induced hepatocarcinogenesis (15) . The protective effect of grapefruit juice, however, does not appear to be due to an enhancement of detoxification capacity because no significant increase in GST activity or GSTA5 or GSH content was observed in livers of grapefruit juice intake rats ( Figures 6B and 7) .
Loe et al. reported that an ATP-dependent transporter, a multidrug resistance protein which controls excretion of chemicals into the intestinal lumen and bile duct, is capable of energy-dependent transport of AFB 1 and its GSH conjugates (35) . It is also known that grapefruit juice intake affects drug availability through an intestinal transporter such as Pglycoprotein (25, 36) . Furthermore, P450-mediated metabolism of AFB 1 in the intestine reduces the AFB 1 concentration in portal blood. Thus, portal blood and liver levels of AFB 1 were quantified to verify whether grapefruit juice intake affects AFB 1 absorption in the gastrointestinal tract. No significant difference in AFB 1 concentration was, however, observed in the portal blood or liver between control and grapefruit juice intake rats (Figure 2) , suggesting that the effect of grapefruit juice intake on absorption of AFB 1 in the gastrointestinal tract is negligible. Thus, our results on AFB 1 concentration indicate that the influence of grapefruit juice intake in rat intestine is unlikely to be reflected in AFB 1 -induced liver DNA damage. It remains unclear why the influence of grapefruit juice intake in rat intestine is unlikely to be reflected in AFB 1 -induced liver DNA damage. Possible explanations are that the major rat intestinal CYP3A forms hardly respond to grapefruit juice and/or metabolize AFB 1 .
The mutagenicity of AFB 1 metabolites with human microsomes was also inhibited by grapefruit juice extracts ( Figure  8B ). We previously reported that furanocoumarin dimers (GF-I-1 and GF-I-4) in grapefruit juice strongly inhibit human CYP3A4 activity (37, 38) . Grapefruit juice components containing these furanocoumarin dimers inhibit not only CYP3A4, but also CYP1A2, CYP2C9 and CYP2C19 (39) . Several reports suggest that CYP3A4 and CYP1A2 are the major forms producing AFBO in humans (40±42). Furthermore, our data showed that grapefruit juice intake can affect hepatic CYP3A activity in rats. Although grapefruit juice is known to selectively inhibit intestinal CYP3A activity, Kivisto et al. suggested that in the human a large intake of grapefruit juice suppresses the activity of CYP3A in both the liver and the intestine (43) . These facts suggest the possibility that AFB 1 -induced DNA damage is also suppressed by grapefruit juice intake in humans through a reduction in hepatic CYP3A activity.
In an Ames assay of AFB 1 genotoxicity, a 20-fold higher concentration of the mycotoxin was required to generate bacterial revertants in the presence of human liver microsomes than was required in the presence of rat liver microsomes ( Figure 8) ; it should be noted that equivalent levels of testosterone 6b-hydroxylation were detected in both rat and human liver microsomes (data not shown). The results of the present study are consistent with a previous report that AFB 1 is less mutagenic in the presence of human liver S9 than in the presence of rat liver S9 (44) . Although these data represent only the capacity for metabolic activation of AFB 1 in liver microsomes, it may provide information on human susceptibility to AFB 1 -induced carcinogenesis.
In the present study we have demonstrated that grapefruit juice intake protects against AFB 1 -induced liver DNA damage in rats and a decrease in hepatic CYP3A activity is at least in part involved in this protection. Fig. 8 . Effect of grapefruit juice extract on AFB 1 -induced mutagenesis in S.typhimurium TA98 with liver microsomes. AFB 1 (0.5, 10 and 20 mg/ reaction) was subjected to Ames assays. Indicated amounts of grapefruit juice extract and (A) rat liver microsomes (50 mg) or (B) human liver microsomes (50 mg) were preincubated prior to the addition of AFB 1 . Ames assays were carried out as described in Materials and methods. Data are shown as means AE SD (n 6).
ÃÃ Significant difference from the vehicle group at P 5 0.01 (0 mg grapefruit juice extract).
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